InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Sachs David C., 首席财务官. Officer active across 1 company, notably ImmunityBio, Inc.. In total, 11 disclosures have been logged. History available since 9 September 2021. The latest transaction was filed on 22 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
David C. Sachs is Chief Financial Officer at ImmunityBio, Inc. He has 11 filings in total, and the sampled recent filings run from 2021-09-13 to 2026-02-24, with the dominant transaction nature shown as option exercise.